A Randomized Trial of Rosuvastatin in the Prevention of Cardiovascular Events Among 17,802 Apparently Healthy Men and Women With Elevated Levels of C-Reactive.
Presenter Disclosure Information Paul M Ridker, MD, FACC Dr Ridker is listed as a co-inventor on patents held by the Brigham and Women’s Hospital that.
JUPITER Primary Trial End Point: MI, Stroke, UA/Revascularization, CV Death
Università Magna Græcia di Catanzaro
A Randomized Trial of Rosuvastatin in the Prevention
Presenter Disclosure Information
